Canada in the front still, imo.. CytoDyn Inc (O
Post# of 148161
Quote:
CytoDyn Inc (OTCQB:CYDY) said that it has submitted the crucial manufacturing section (CMC) of the application, for an interim order to Health Canada for its flagship drug leronlimab to be considered as a medical treatment for coronavirus (COVID-19), under a rolling review.